相关实验视频

Updated: May 21, 2025

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

通过抑制PI3K/Akt/mTOR通路,Sema3A通过降低eIF2α酸化来缓解神经病痛

Tingting Hu¹, Miaoyi Pang², Qingyu Sun²

¹Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Tianjin Huanhu Hospital, Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Neurosurgical Institute, Tianjin 300222, China.

The journal of pain

|March 19, 2025

概括

赛马林3A (Sema3A) 通过抑制PI3K/Akt/mTOR通路和真核细胞启动因子2α (eIF2α) 酸化来缓解神经病痛. 这一发现为缓解疼痛提供了新的治疗点.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
疼痛研究疼痛研究

背景情况:

主要感觉神经元连接了外周和中枢神经系统,传输疼痛信号.
周围神经损伤可能导致神经纤维再生和严重的神经病痛.
赛马福林3A (Sema3A) 抑制神经再生,但其在神经病痛中的作用尚不清楚.

研究的目的:

为了研究Sema3A在神经病痛中的作用.
探索Sema3A在疼痛中的作用的潜在分子机制.
为了确定神经病痛疼痛缓解的潜在治疗点.

主要方法:

使用了一种慢性收缩损伤 (CCI) 鼠标神经病痛模型.
通过注射,Sema3A在背部根结节 (DRG) 神经元中过度表达.
分析了PI3K/Akt/mTOR信号通路和eIF2α酸化.
使用PKR和PERK抑制剂来评估对离子通道表达的影响.

主要成果:

增加Sema3A表达减轻了CCI小鼠的机械和热感知行为.
在DRG神经元中,Sema3A过度表达抑制了PI3K/Akt/mTOR通路和eIF2α酸化.
抑制eIF2α酸化减少了离子通道表达和神经病痛.
通过抑制PI3K/AKT/mTOR通路,Sema3A抑制了eIF2α酸化.

结论:

在DRG神经元中Sema3A表达的减少与外围神经损伤有关.
提高Sema3A水平通过调节PI3K/Akt/mTOR通路和eIF2α酸化来缓解神经病痛.
塞马3A和eIF2α酸化是神经病痛治疗的潜在治疗点.

关键词:

背部根系关节的发生.单核细胞启动因子2α 神经病变性疼痛神经病变性疼痛塞马福林3A 是一种

更多相关视频

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice

Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice

Published on: January 25, 2022

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Analgesia and Pain Management

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...